Cited by 29Pharmacogenetics and Drug MetabolismPharmaceutical studies and practicesAnimal testing and alternatives

The DOI matches its Crossref record; the references it cites are not checked yet.

Prediction of Clearance in Humans from In Vitro Human Liver Microsomes and Allometric Scaling. A Comparative Study of the Two Approaches

Mahmood,, I.·2002·Drug Metabolism and Drug Interactions

Abstract

The objective of this study was to evaluate whether the predicted clearance of a drug in humans from in vitro human liver microsomes was comparable with the predicted clearance in humans obtained by allometric scaling. Sixteen drugs were randomly selected from the literature and their hepatic clearances were predicted using human liver microsomes. For allometric scaling at least three animal species were used and three methods were utilized to generate allometric equations to predict the clearance in humans: (i) clearance vs body weight (simple allometry); (ii) product of the clearance and maximum life-span potential (MLP) vs body weight; and (iii) the product of clearance and brain weight vs body weight. The choice of one of the methods was based on the 'rule of exponents' as described by Mahmood and Balian /2,3/. The results of this study indicated that the use of human liver microsomes to predict hepatic clearance in humans may not provide reliable predictions. On the other hand, the prediction of clearance in humans using allometric scaling combined with the 'rule of exponents' can provide comparatively better prediction of clearance in humans.

Overview

Integrity signals

Registry

Crossref · 10.1515/dmdi.2002.19.1.49

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists haven’t been fetched yet

References 47 · Cited by 29

Research works printed but not linked: 45

  1. 10.1007/BF01059667 · DOI · Paper page
  2. 10.3109/03602538409033558 · DOI
  3. 10.1007/BF03189622 · DOI
  4. Obach RS, 1997, J Pharmacol Exp Ther, 283, 46, 10.1016/S0022-3565(24)36999-X · DOI · Paper page
  5. 10.1021/js9702628 · DOI
  6. 10.1080/004982598238859 · DOI
  7. 10.1016/S0163-7258(96)00184-2 · DOI · Paper page
  8. Sacher G, 1959, CIBA Foundation Colloquia on Aging. London: Churchill, 115
  9. BoxenbaumΗ C, 1995, J Clin Pharmacol, 35, 957, 10.1002/j.1552-4604.1995.tb04011.x · DOI
  10. 10.1016/0006-2952(94)90520-7 · DOI · Paper page
  11. 10.1097/00008571-199412000-00010 · DOI
  12. Klotz U, 1976, J Pharmacol Exp Ther, 199, 67, 10.1016/S0022-3565(25)30657-9 · DOI
  13. 10.1002/jat.2550090509 · DOI
  14. 10.1002/jps.2600710723 · DOI
  15. 10.1007/BF00510985 · DOI
  16. 10.1007/BF01059331 · DOI
  17. 10.1002/jps.2600801203 · DOI
  18. 10.1097/00008571-199910000-00002 · DOI
  19. 10.1038/clpt.1989.5 · DOI
  20. 10.1080/004982599238687 · DOI
  21. 10.1046/j.1365-2125.2001.00318.x · DOI
  22. Rane A, 1984, J Pharmacol Exp Ther, 228, 774, 10.1016/S0022-3565(25)21973-5 · DOI
  23. Belpaire FM, 1990, J Pharmacol Exp Ther, 254, 116, 10.1016/S0022-3565(25)12609-8 · DOI
  24. Murthy SS, 1991, Drug Metab Disp, 19, 1093, 10.1016/S0090-9556(25)09040-3 · DOI
  25. 10.1007/BF03190855 · DOI
  26. Kim M, 1993, Drug Metab Disp, 21, 309, 10.1016/S0090-9556(25)08097-3 · DOI
  27. 10.1023/A:1018914816137 · DOI
  28. 10.3109/00498259209053133 · DOI
  29. 10.1016/S0278-5846(82)80180-2 · DOI
  30. 10.1159/000028333 · DOI
  31. Evans GH, 1973, J Pharmacol Ther, 186, 114, 10.1016/S0022-3565(25)29572-6 · DOI
  32. Marathe PH, 1994, Drug Metab Disp, 22, 237, 10.1016/S0090-9556(25)08364-3 · DOI
  33. Chang KHT, 1993, Cancer Res, 53, 5629
  34. Dusterberg B, 1986, Arzneim-Forsch, 36, 1187
  35. Purba HS, 1987, Br J Clin Pharmacol, 23, 447, 10.1111/j.1365-2125.1987.tb03074.x · DOI
  36. Izumi T, 1996, J Pharmacol Exp Ther, 277, 1630, 10.1016/S0022-3565(25)13117-0 · DOI
  37. 10.2165/00003088-199937020-00001 · DOI
  38. Stryd RP, 1992, Pharm Res, 9, S312, 10.1023/A:1015826532087 · DOI
  39. Wienkers LC, 1996, J Pharmacol Exp Ther, 277, 982, 10.1016/S0022-3565(25)12957-1 · DOI
  40. Wienkers LC, 1996, J Pharmacol Exp Ther, 287, 583, 10.1016/S0022-3565(24)37831-0 · DOI
  41. Riekosezewski W, 1993, Drug Metab Disp, 21, 690, 10.1016/S0090-9556(25)07474-4 · DOI
  42. Venkataramanan R, 1990, Transplant Prog, 22, 52
  43. 10.2165/00003088-199529060-00003 · DOI
  44. 10.1016/0006-2952(94)90136-8 · DOI
  45. Mahmood I, 2001, Drug Metab Drug Interact, 18, 135, 10.1515/DMDI.2001.18.2.135 · DOI

Metadata

Authors
Mahmood
Affiliations
Center for Biologics Evaluation and Research (US)
Corresponding author
Mahmood,, I.
Venue
Drug Metabolism and Drug Interactions
Published
2002-09
Volume
19
Issue
1
Pages
49-64
ISSN
  • 0334-2190 (ISSN-L)
  • 2191-0162
  • 0792-5077
OpenAlex
W2315133816
Cited by
29
References
47
Citations by year
2024: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2015: 2 · 2014: 1 · 2012: 3
FWCI
1.02
Type
journal article
Language
en
Open access
closed
Locations
  • Drug metabolism and drug interactions (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
Keywords
human liver microsomes, allometric scaling, brain weight, body weight, in vitro-in vivo extrapolation, drug metabolism
MeSH terms
Animals, Biometry, Body Weight, Brain, Humans, Life Expectancy, Metabolic Clearance Rate, Microsomes, Liver, Models, Chemical, Organ Size, Pharmacokinetics, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review